Generics -

Filter

Current filters:

Popular Filters

176 to 200 of 1237 results

Teva gains favorable court ruling in Azilect patent case

Teva gains favorable court ruling in Azilect patent case

24-09-2013

Israel-based Teva Pharmaceutical Industries has gained a favorable ruling in its patent infringement…

AzilectGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaTeva Pharmaceutical Industries

Australia needs policies that increase generic medicine use

24-09-2013

Australia’s Generic Medicines Industry Association strongly refutes claims by the Consumer Health Forum…

Asia-PacificGenericsMarkets & MarketingPolitics

US generics industry files Citizen Petition on biosimilar naming

20-09-2013

The USA’s Generic Pharmaceutical Association (GPhA) has filed an official Citizen Petition with the…

GenericsNorth AmericaRegulation

Philippines Food and Drug Administration promotes generics medicine

19-09-2013

The Philippines Department of Health Foods and Drugs Administration (PFDA) today launched the Generics…

Asia-PacificGenericsHealthcare

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

US FDA approves first generic Xeloda for colorectal and breast cancers

17-09-2013

The US Food and Drug Administration approved the first generic version of Swiss drug major Roche's (ROG:…

capecitabineGenericsNorth AmericaOncologyRegulationRocheTeva Pharmaceutical IndustriesXeloda

Promising outcome of EU platform on access to medicines in Africa

17-09-2013

The Platform on Access to Medicines in Developing Countries with a Focus on Africa took a step forward…

EuropeFinancialGenericsHealthcarePharmaceuticalRest of the World

Ban on FDA-regulated drugs from Ranbaxy's Mohali plant

17-09-2013

There was another blow for India's largest drugmaker Ranbaxy Laboratories (BSE: 500359) yesterday (September…

Asia-PacificDaiichi SankyoGenericsNorth AmericaProductionRanbaxy LaboratoriesRegulation

Increase of Japan's medical expenditure slowed to 1.7% in 2012

17-09-2013

The Japanese Ministry of Health, Labor and Welfare (MHLW) reported approximate medical expenditure (AME)…

Asia-PacificFinancialGenericsHealthcarePharmaceutical

Clawback taxation mechanism for generic drugs changes planned for Romania

16-09-2013

By year-end, the government of Romania will draw up new legislation that changes the clawback taxation…

EuropeGenericsPricing

Canada's Health Minister sets out plan to help reduce impact of drug shortages

16-09-2013

A national protocol for the public notification of drug shortages and a toolkit that identifies steps…

GenericsHealthcareNorth AmericaPharmaceuticalRegulation

Generics market in Southeast Asia set for growth

15-09-2013

With its fast-growing, young population and uninsured majority in Southeast Asia, countries in the region…

Asia-PacificGenericsMarkets & MarketingPricingRegulation

Advance Pharmaceutical to invest $25 million in building plant in Russia

13-09-2013

USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility…

Advance PharmaceuticalEuropeFinancialGenericsPharmaceuticalProduction

Adcock Ingram agrees takeover terms with CFR

12-09-2013

Adcock Ingram (AIP: SP), one of South Africa's largest drugmakers, has provided further details of the…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

UK lags behind some European countries in biosimilars uptake, new study finds

12-09-2013

New research has shown that the UK lags behind some European countries in terms of biosimilars uptake,…

CellTrionepoetinEuropeFilgrastimGenericsHealthcareinfliximabJohnson & JohnsonRemsima

EGA welcomes first biosimilar MAb approvals in Europe

12-09-2013

Following the European Medicines Agency's CHMP recommendation, the European Commission (EC) has just…

Anti-Arthritics/RheumaticsBiotechnologyGenericsPricingRegulation

First biosimilar monoclonal antibody approved in Europe

10-09-2013

US injectables and infusion technologies firm Hospira (NYSE: HSP) says the European Commission has approved…

Anti-Arthritics/RheumaticsBiotechnologyCellTrionEuropeGenericsHospiraInflectraMerck & CoRemicadeResearch

Japan's MHLW to expand program on educating patients on cost of branded drugs

10-09-2013

The Japanese Ministry of Health, Labor and Welfare (MHLW) plans to expand a program to notify patients…

Asia-PacificFinancialGenericsHealthcare

Avanir Pharma patent settlement with Wockhardt

08-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Ireland's HSE announces preferred ACE inhibitor and ARBs

06-09-2013

Ireland Health Service Executive's (HSE) Medicines Management Program (MMP) has identified two new preferred…

Cardio-vascularEuropeFinancialGenericsPricing

Final approval for California's SB 598 Biosimilars Bill

05-09-2013

A bill updating US State of California's pharmacy substitution law to allow greater patient access to…

BiotechnologyGenericsLegalNorth AmericaRegulation

Bayer in settlement over Cipro pricing

04-09-2013

A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

176 to 200 of 1237 results

Company Spotlight

Fibrotech

Fibrotech

Back to top